AmebaGone

About:

AmebaGone is developing proprietary technologies uses novel biocontrol method to destroy intractable bacterial infections.

Website: http://www.amebagone.com

Top Investors: National Science Foundation, Cleantech Open, Wisconsin Economic Development

Description:

AmebaGone Inc. will solve one of the 21st century’s most compelling problems -- that of growing antibiotic resistance alongside a dwindling supply of effective antimicrobial products. Antibiotic resistance is a worldwide problem that manifests itself in agriculture, medicine, and industry. And while the threat of infectious disease is intensifying, the discovery of new antibiotics has slowed dramatically. Pharmaceutical companies have largely abandoned the discovery of new antibiotics, despite the likelihood of an impending health crisis.

Total Funding Amount:

$1.15M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2010-01-01

Contact Email:

amebagone(AT)amebagone.com

Founders:

Marcin Filutowicz

Number of Employees:

1-10

Last Funding Date:

2020-09-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai